Free Initial Consultation
Local:
636-530-9199
Toll Free:
866-585-4570
defective drug attorneys st louis

Testosterone Drugs Now Under Scrutiny

You may have seen it advertised quite a bit in the past year: prescription drugs aimed at treating low testosterone levels in men, or “low T,” as they call it. Recently, a study released by the University of North Texas has shown a possible correlation between an increased risk for brain damage among some men.
The study found an increased risk of brain damage—a very serious side-effect for any drug—in Caucasian men involved in the study, but not among Mexican-American men. In addition to this university study, the FDA has also been investigating possible side-effects related to testosterone therapy drugs. Several lawsuits have also been filed against the manufacturers of some of the drugs.
For more information on how the drug litigation attorneys at The Roberts Law Firm can help you if you have been affected by a serious side-effect of a prescription drug, please contact us.

Risperdal Use Linked to Diabetes

One troubling side effect of Risperdal is that it may increase the patient’s risk of diabetes. This risk is associated with another common side effect of Risperdal: weight gain. The combination of weight gain and Risperdal use can lead to a frightening mixture.
Among the litany of startling side effects, diabetes is especially troubling. The use of Risperdal perhaps accentuates the otherwise undiagnosed diabetic symptoms in the patient, but diagnosed or not, diabetes can be fatal.
Usually the most prevalent symptoms of diabetes are increased levels of thirst and frequent urination, unintended weight loss, constant fatigue, digestive issues, tingling sensation in the feet, slow healing cuts and bruises, and vision problems. If left undiagnosed, diabetes can lead to heart disease, nerve damage, stroke, and eventual blindness.
If you or a loved one are experiencing any of these symptoms, contact your family physician as soon as possible.

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.